ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value (RCKT)

Historical Holders from Q1 2018 to Q1 2025

Symbol
RCKT on Nasdaq
CUSIP
77313F106
Type / Class
Equity / Common Stock, $0.01 par value
Shares outstanding
107M
All holders as of December 31, 2024
Q4 2024
Shares, excl. options
110M
Holdings value
$1.38B
% of all portfolios
0.003%
Grand Portfolio weight change
+0%
Number of holders
222
Number of buys
139
Number of sells
-68
Average Value change %
+0%
Average buys %
+0.001%
Average sells %
-0.001%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value (RCKT)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
WELLINGTON MANAGEMENT GROUP LLP 13.4% $93.3M 14M Wellington Management Group LLP Dec 31, 2024
MAVERICK CAPITAL LTD 5.2% $37M 5.55M Maverick Capital, Ltd. Apr 7, 2025

Institutional Holders of ROCKET PHARMACEUTICALS, INC. - Common Stock, $0.01 par value (RCKT)

Period Reported Shares, Excl. Options Value, Excl. Options Change Price Investors
2025 Q1 959K $6.38M +$1.51M $6.67 18
2024 Q4 110M $1.38B +$165M $12.57 222
2024 Q3 92.5M $1.71B +$15.9M $18.47 189
2024 Q2 91.2M $1.96B -$31.8M $21.53 179
2024 Q1 92M $2.48B +$111M $26.94 187
2023 Q4 89M $2.67B +$5.21M $29.97 191
2023 Q3 89.1M $1.83B +$246M $20.49 172
2023 Q2 76.1M $1.51B -$36.1M $19.87 160
2023 Q1 78.2M $1.34B +$44.2M $17.13 158
2022 Q4 75.9M $1.49B +$146M $19.57 163
2022 Q3 69M $1.1B +$65.7M $15.96 154
2022 Q2 64.5M $887M +$4.03M $13.76 138
2022 Q1 62.5M $991M +$10.1M $15.86 138
2021 Q4 63.1M $1.38B +$9.18M $21.83 137
2021 Q3 61.5M $1.84B -$26M $29.89 140
2021 Q2 61.7M $2.73B -$54.4M $44.29 143
2021 Q1 61.9M $2.75B -$19.1M $44.37 169
2020 Q4 61.9M $3.39B +$435M $54.84 169
2020 Q3 55.1M $1.26B +$22.9M $22.86 121
2020 Q2 53.2M $1.11B +$14.4M $20.93 112
2020 Q1 52M $725M +$12.4M $13.95 99
2019 Q4 51.1M $1.16B +$87.9M $22.76 115
2019 Q3 43.3M $504M -$33.1M $11.65 88
2019 Q2 47M $705M +$95.7M $15.00 93
2019 Q1 39.9M $699M +$16.5M $17.54 78
2018 Q4 38.6M $570M +$71.2M $14.82 82
2018 Q3 33.8M $832M +$69.9M $24.62 80
2018 Q2 31.1M $605M +$63.9M $19.63 75
2018 Q1 28M $502M +$502M $18.75 55